273 related articles for article (PubMed ID: 20978862)
1. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.
Juday T; Tang H; Harris M; Powers AZ; Kim E; Hanna GJ
J Gen Intern Med; 2011 Mar; 26(3):239-44. PubMed ID: 20978862
[TBL] [Abstract][Full Text] [Related]
2. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
Sarkar M; Shvachko VA; Ready JB; Pauly MP; Terrault NA; Peters MG; Manos MM
Dig Dis Sci; 2014 Sep; 59(9):2100-8. PubMed ID: 24728968
[TBL] [Abstract][Full Text] [Related]
4. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
Wong RJ; Nguyen MT; Trinh HN; Chan C; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Torres S; Yang J; Liu B; Garcia RT; Bhuket T; Baden R; Levitt B; da Silveira E; Gish RG
J Viral Hepat; 2017 Dec; 24(12):1089-1097. PubMed ID: 28581644
[TBL] [Abstract][Full Text] [Related]
6. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-Up.
Joshi SS; Gao S; Castillo E; Coffin CS
Dig Dis Sci; 2020 Jan; 65(1):204-214. PubMed ID: 31376084
[TBL] [Abstract][Full Text] [Related]
7. Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019.
Pham TTH; Toy M; Hutton D; Thompson W; Conners EE; Nelson NP; Salomon JA; So S
Med Care; 2023 Apr; 61(4):247-253. PubMed ID: 36893410
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
[TBL] [Abstract][Full Text] [Related]
9. Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Song BC; Cho YK; Jwa H; Choi EK; Kim HU; Song HJ; Na SY; Boo SJ; Jeong SU
Clin Mol Hepatol; 2014 Dec; 20(4):355-60. PubMed ID: 25548741
[TBL] [Abstract][Full Text] [Related]
10. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
Chen L; Shi J; Lu Z; Ye Y; Zhou X; Tan Y
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):310-316. PubMed ID: 30528063
[TBL] [Abstract][Full Text] [Related]
11. [Antiviral nucleotide-induced dynamic change of HBV DNA and HBsAg and significance of quarterly and annual quantitative measurements over 5-year follow-up of chronic hepatitis B patients].
Xi HL; Li MR; Bao Y; Yu M; Qin XQ; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):821-4. PubMed ID: 24331690
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccination in chronic hepatitis B.
Senturk H; Tabak F; Akdogan M; Erdem L; Mert A; Ozaras R; Sander E; Ozbay G; Badur S
J Gastroenterol Hepatol; 2002 Jan; 17(1):72-6. PubMed ID: 11895556
[TBL] [Abstract][Full Text] [Related]
13. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.
Hadziyannis SJ; Sevastianos V; Rapti I; Vassilopoulos D; Hadziyannis E
Gastroenterology; 2012 Sep; 143(3):629-636.e1. PubMed ID: 22659218
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
[TBL] [Abstract][Full Text] [Related]
15. Laboratory monitoring and antiviral treatment for chronic hepatitis B among routine care patients in the United States.
Zhou Y; Li J; Gordon SC; Trudeau S; Rupp LB; Boscarino JA; Daida YG; Schmidt MA; Lu M
J Viral Hepat; 2022 Mar; 29(3):189-195. PubMed ID: 34905259
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
17. Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
McMahon BJ
Am J Med; 2008 Dec; 121(12 Suppl):S45-52. PubMed ID: 19185074
[TBL] [Abstract][Full Text] [Related]
18. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa.
Buster EH; Hansen BE; Lau GK; Piratvisuth T; Zeuzem S; Steyerberg EW; Janssen HL
Gastroenterology; 2009 Dec; 137(6):2002-9. PubMed ID: 19737568
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
20. [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment].
Veldhuijzen IK; Mostert MC; Niesters HG; Richardus JH; de Man RA
Ned Tijdschr Geneeskd; 2008 Jun; 152(25):1426-30. PubMed ID: 18624006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]